Navigation Links
FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
Date:11/14/2007

ith teriparatide and

3.9 plus or minus 0.6 percent increase with alendronate at 18

months (P < 0.001)

-- The mean increase in total hip BMD with teriparatide was significantly

greater compared with alendronate after 12 months (first measurement

at the hip) through 18 months of therapy

-- 3.8 plus or minus 0.6 percent increase with teriparatide and

2.4 plus or minus 0.6 percent increase with alendronate at 18

months (P < 0.01)

-- A preliminary analysis of new radiographic vertebral fractures in

patients with baseline and 18 month radiographs showed that one

patient receiving teriparatide (0.6 percent; 1 out of 171 patients)

and 10 patients receiving alendronate (6.1 percent; 10 out of 165

patients) had greater than or equal to 1 new vertebral fracture

-- A preliminary analysis of nonvertebral fracture showed that 12

patients receiving teriparatide (5.6 percent; 12 out of 214 patients)

and eight patients receiving alendronate (3.7 percent; 8 out of 214

patients) had greater than or equal to 1 new nonvertebral fracture

There was no significant difference overall in the number of patients reporting adverse events in patients receiving teriparatide compared with alendronate.(1) Significant differences between groups in individual adverse events included nausea, insomnia, pharyngitis, and viral infection reported by more patients receiving teriparatide than alendronate, and rash, weight decrease, sciatica, and asthma reported by more patients receiving alendronate than teriparatide.(1) A significantly higher proportion of teriparatide than alendronate patients had at least one post-baseline calcium in the hypercalcemia range (18.0 percent [38 out of 211 patients] for teriparatide and 5.7 percent [12 out of 207 patients] for alendronate (P < 0.001).(1)

To view the published manuscript,
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Seriously Low Vaccination Rates Cause Experts to Call for Increased Immunization Before Influenza Season Peaks
2. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
3. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
4. Superbug Outbreak Calls for Immediate Increased Attention on Infection Control
5. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
6. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
7. Syndicom SpineConnect Web Platform Chosen for Applied Spines Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System
8. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015 BioElectronics Corporation (OTC Pink: BIEL), ... Therapy medical devices, announced today that its registry ... trial device has been published in the prominent ... http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 chronic pain ... assessment.  Chronic pain is a ...
(Date:8/4/2015)... EDISON, N.J. , Aug. 4, 2015 /PRNewswire/ ... biopharmaceutical company focused on the development and commercialization ... Sapirstein , Chief Executive Officer, will present live ... DATE: Thursday, August 6, 2015 TIME: 12:15PM EDT ... will be a live, interactive online event where ...
(Date:8/4/2015)... 4, 2015  Ironshore Pharmaceuticals & Development, Inc. ... a company specializing in personalized medicine, to participate ... designed to evaluate the safety and efficacy of ... Attention-deficit/hyperactivity disorder (ADHD). This is Restore,s second clinical ... originally partnered with Ironshore in 2014 and continues ...
Breaking Medicine Technology:BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 3Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2
... voluntary recall of ALL lots of its Ketorolac Tromethamine Injection, USP ... NDC# 0517-0601-25 15 mg/mL ... This recall is in addition to the voluntary recall initiated on ... unexpired lots of Ketorolac Tromethamine Injection, USP, 30 mg/mL ...
... a next-generation oncology diagnostics company focused on improving ... closed a $21 million series A financing. ... and included Bessemer Venture Partners, Physic Ventures and ... ) , On-Q-ity is developing diagnostics to determine ...
Cached Medicine Technology:American Regent Expands Voluntary Recall to Include All Lots of Ketorolac Tromethamine Injection, USP 15 mg/mL; 1mL Single Dose Vials 2Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 2
(Date:8/4/2015)... ... August 04, 2015 , ... ... Angeles commercial customers. Finding reliable hardware can be difficult and troublesome for ... putting an office together or designing a new facility, it is imperative to ...
(Date:8/4/2015)... ... August 04, 2015 , ... PerceptiMed, Inc. announces the addition ... FACS, to its Board of Directors effective August 1, 2015. , "PerceptiMed's ... "I strongly believe in the mission of the company and the capabilities of ...
(Date:8/4/2015)... ... August 04, 2015 , ... Recent ... locations have shown a rise in binge drinking among certain populations ... and depression, are continuing to examine trends and evidence to help facilitate health ...
(Date:8/4/2015)... ... , ... 24/7 Care At Home , a provider of comprehensive home ... that the U.S. Department of Veteran’s Affairs (VA) has awarded its agency a rating ... on the path to meeting the aspirational goals the VA promotes each year. ...
(Date:8/4/2015)... Calif. (PRWEB) , ... August 04, 2015 , ... ... corporations, law firms and government entities, today announced that John Munro, a 15-year ... as Vice President of Managed Services Operations. , “I am thrilled to join ...
Breaking Medicine News(10 mins):Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3Health News:24/7 Care At Home Receives Two Stars from the VA 2Health News:24/7 Care At Home Receives Two Stars from the VA 3Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 2Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 3
... India is on the rise and is rapidly becoming the number ... spot. The seriousness of the situation is apparent after going through ... ,The rise is being documented mainly in the metros, ... areas go unnoticed. It is reported that one in 22 women ...
... The Productivity Commission of Australia has recommended a report which ... consultation with out referral from the physician. // ... report as they feel that the move will help to ... and a consultation straightly with the specialist will help the ...
... People who surf the web do not take more than ... worth it or not, according to recent scientific findings. The ... ,‘My colleagues believed it would be impossible to ... Gitte Lindgaard of Carleton University in Ottawa, who has published ...
... Medicare appears to be backfiring badly in the United States ... without essential medicines and were forced to wait for the ... citizens do not properly understand Medicare’s new prescription drug plans ... again they have no option and have to enroll themselves ...
... improvements made in diagnoses and treatment of the fatal ... a cure rate of 90%, according to researchers belonging ... ,The progressive improvement in the cure rate since ... reflects in large part the more effective use of ...
... for Health and Clinical Excellence (NICE) has found that anti-cholinesterase ... is not very effective in controlling the disease as the ... have reported that the drug action is not worth its ... one reaches forty years. Once affected, Alzheimer's gradually destroys the ...
Cached Medicine News:Health News:Acute Lymphoblastic Leukemia May Attain a 90% Cure Rate 2
Spacelabs offers an approach that allows your telemetry and step-down units to configure systems to meet their telemetry requirements. Our modular telemetry system data are integrated into the depart...
The Tele-Pro WEP-4200 Telemetry System is an 8-Patient Stand Alone System. Offering capabilities such as arrhythmia analysis, trends and full disclosure, the Tele-Pro is a system to help hospitals to...
ISI Ultra-Light Specialty Table offers the ultimate accessibility for surgeons, technicians and equipment during upper extremity surgeries....
Ademtechs Magnetic Beads are produced by encapsulation of a magnetic oil (patented technology). The magnetic content, uniform particle size, mono-dispersion properties, and the high surface area allo...
Medicine Products: